[This review was originally posted at the Nieman Journalism Lab Bactrim Price, on April 29, 2011.]

Leaking gets competitive: WikiLeaks made its first major document release in five months — during which time its founder, Julian Assange, was arrested, released on bail, and put under house arrest — this week, publishing 764 files regarding the Guantánamo Bay prison along with 10 media partners. (As always, The Nation's Greg Mitchell's WikiLeaks über-blogging is the place to go for every detail you could possibly need to know.)

That's more media partners than WikiLeaks has worked with previously, and it includes several first-timers, such as the Washington Post and McClatchy. As the Columbia Journalism Review's Joel Meares noted, Where can i buy Bactrim online, the list of partners doesn't include the New York Times and the Guardian, the two English-language newspapers who worked with WikiLeaks in its first media collaboration last summer. Despite being shut out, those two organizations were still able to force WikiLeaks' hand in publishing the leak, as the Huffington Post's Michael Calderone explained.

The Times got their hands on the documents independently, then passed them on to the Guardian and NPR, order Bactrim no prescription. This meant that, unlike the news orgs that got the info from WikiLeaks, they were operating without an embargo, Bactrim Price. As they prepared to publish last Sunday, WikiLeaks lifted its embargo early for its own partners (though the first to publish was actually the Telegraph, a WikiLeaks partner).

The New York Times' Brian Stelter and Noam Cohen said the episode was evidence that WikiLeaks "has become such a large player in journalism that some of its secrets are no longer its own to control." But, as they reported, Bactrim photos, WikiLeaks itself didn't seem particularly perturbed about it.

—

Patch's reaches for more bloggers: AOL seems to be undergoing a different overhaul every week since it bought the Huffington Post earlier this year, and this week the changes are at its hyperlocal initiative Patch, which is hoping to add 8,000 community bloggers to its sites over the next week or two in what its editor-in-chief called a "full-on course correction."

While talking to paidContent, AOL's folks played down the degree of change it's implementing, explaining that these new bloggers (who will be recruited from, Bactrim recreational, among other sources, the sites' frequent commenters) aren't disrupting the basic Patch model of one full-time editor per site. In fact, they'll be unpaid, something that's been a bit of a headache for AOL and HuffPo lately.

Business Insider's Nicholas Carlson liked the plan Bactrim Price, , saying volunteer bloggers can become "extremely effective word-of-mouth marketers" and "excellent pageview machines" with, of course, "manageable" salaries. Bactrim class, Others from MediaBistro and Wired were a little more skeptical of the no-pay factor. Lehigh j-prof Jeremy Littau took issue with a more systemic aspect of the new blogs, which will exist both on the writer's own site and on Patch. Splitting up the conversation with that arrangement won't be helpful for the individual blogs or for the local blogosphere as a whole, he said: "I see something developing that leads to less population in the local blogosphere and a walled-off system that operates on Patch. At worst, it will lead to parallel and fracture conversations online, which is death when we’re talking about hyperlocal."

—

Two new media manifestos: Two New York j-profs — and two of the more prominent future-of-news pundits online these days — both published manifestos of sorts this week, effects of Bactrim, and both are worth a read. Jay Rosen summed up what he's learned about journalism in 25 years of teaching and thinking about it at NYU, and CUNY's Jeff Jarvis gave a few dozen bullet points outlining his philosophy of news economics.

Rosen's post touched on several of the themes that have colored his blog and Twitter feed over the past few years, including the value of increasing participation, the failure of "objectivity," and the need for usefulness and context in news, Bactrim Price. But the ideas weren't exactly new, the conversation they generated was stimulating. Bactrim interactions, The comments chase down some interesting tangents, and GigaOM's Mathew Ingram expanded on Rosen's point about participation, arguing that even if the number of users who want to participate is relatively low, opening up the process can still be immensely important in improving journalism. Rosen also inspired TBD's Steve Buttry to write his own "what I know about news" post.

Like Rosen's post, Jarvis' wouldn't break a whole lot of ground for those already familiar with his ideas, my Bactrim experience, but it summed them up in a helpfully pithy format. Bactrim Price, He focused heavily on providing real value ("The only thing that matters to the market is value"), the importance of engagement, and finding efficiencies in infrastructure and collaboration. His post contains plenty of pessimism about the current newspaper business model, and Mathew Ingram and FishbowlNY's Chris O'Shea defended him against the idea that he's just a doomsayer.

—

Times paywall bits: The New York Times spent a reported $25 million to develop its paid-content system, and it will be spending another $13 million on the plan this year, Bactrim without prescription, mostly for promotion. Women's Wear Daily detailed those promotional efforts, which include posters around New York as well as TV spots. PaidContent's Robert Andrews compared the Times' pay plan to that of theother Times (the one in London, owned by Rupert Murdoch), noting that the New York Times' plan should allow them to draw more revenue while maintaining their significant online influence, something the Times of London hasn't done at all (though it's largely by choice), Bactrim from canadian pharmacy.

Meanwhile, Terry Heaton found another (perhaps more convoluted) way around the Times' system, tweeting links to Times stories that he can't access, Bactrim Price. And elsewhere at the Times, the Lab's Megan Garber explored the Times' R&D Lab's efforts to map the way Times stories are shared online.

And elsewhere in paywalls, the CEO of the McClatchy newspaper chain has reversed his anti-paywall stance and said this week the company is planning paywalls for some of its larger papers, and Business Insider introduced us to another online paid-content company, Buy Bactrim online no prescription, Tiny Pass.

—

Apps, news, and pay: In his outgoing post on Poynter's Mobile Media blog, Damon Kiesow had a familiar critique for news organizations' forays into mobile media — they're too much like their print counterparts to be truly called innovative. But he did add a reason for optimism, pointing to the New York Times' News.me and the Washington Post's Trove: "Neither is a finished product or a perfect one, get Bactrim. But both were created by newspaper companies that put resources into research and development."

Media analyst Ken Doctor said Bactrim Price, local news needs to start moving toward mobile media to reach full effectiveness, laying out the model of an aggregated local news app pulling various types of media. For maximum engagement, that app had better include audio, according to some NPR statistics reported by the Lab's Andrew Phelps.

There may a bigger place for paid apps than we've thought: Instapaper's Marco Arment twice pulled the free version of the app for about a month and found that sales actually increased. He made the case against free apps, Kjøpe Bactrim på nett, köpa Bactrim online, saying they bring low conversion rates, little revenue, and unnecessary image problems. Meanwhile, makers of one free app, Zite, said they're releasing a new version to deal with complaints they've been getting from publishers about copyright issues, about Bactrim.

—

Reading roundup: No big stories this week, but tons of little things to keep up on, Bactrim Price. Here's a bit of the basics:

— On social media: Facebook launched a "Send" plugin among a few dozen websites (including a couple of news sites) that allows private content-sharing. The Next Web's Lauren Fisher argued that journalists should spend more time using Facebook, and Canadian j-prof Alfred Hermida wrote about a study he helped conduct about social media and news consumption.

— The Guardian shut down a local-news project it launched last year, saying the local blogs were "not sustainable." PaidContent's Robert Andrews said that while the blogs were useful, Bactrim cost, there are few examples of sustainable local-news efforts, and Rachel McAthy of Journalism.co.uk rounded up some opinions to try to find the value in the Guardian's experiment.

— The news filtering program launched in public beta this week, prompting a New York Times profile and pieces by GigaOM's Mathew Ingram and the Knight Digital Media Center's Amy Gahran on the journalistic value of curation.

— Thanks to its most recent content-farm-oriented algorithm tweak, Google's traffic to all Demand Media sites is down 40%, which caused Demand stock to slide this week. Google, meanwhile, added some more automatic personalization features to Google News.

— The Lab's Andrew Phelps wrote a great piece expounding on the journalistic utility of the humble (well, kind of humble) smartphone.

— And for your deep-thinking weekend-reading piece, Harvard researcher Ethan Zuckerman's thoughtful take on overcoming polarization by understanding each other's values, rather than just facts.

Similar posts: Flagyl Price. Order Zoloft. Purchase Tramadol. Buy Cephalexin online cod. Cephalexin long term. Cipro use.
Trackbacks from: Bactrim Price. Bactrim Price. Bactrim Price. Bactrim natural. Buy Bactrim without a prescription. Doses Bactrim work.

[This review was originally posted at the Nieman Journalism Lab Synthroid No Rx, on April 22, 2011.]

Is Flipboard a competitor or collaborator?: Flipboard has quickly become one of the hottest news apps for the iPad, and it continued its streak last week when it announced it had raised $50 million in funding. Flipboard's Mike McCue told All Things Digital's Kara Swisher he'd be using the money to hire more staff and expand onto other devices, including the iPhone and Android platform. But he also talked to TechCrunch about using the money to fend off a rumored competitor in development at Google. (The Houston Chronicle's Dwight Silverman told Google not to bother, because Zite already does the trick for him.)

All this prompted a fantastic analysis of Flipboard from French media consultant Frederic Filloux, buying Synthroid online over the counter, who explained why Flipboard's distinctive user-directed blend of news media sites, RSS feeds, and social media is so wonderful for users but so threatening to publishers. Filloux argued that every media company should be afraid of Flipboard because they've built a superior news-consumption product for users, Where to buy Synthroid, and they're doing it on the backs of publishers. But none of those publishers can complain about Flipboard, because any of them could have (and should have) invented it themselves.

GigaOM's Mathew Ingram advised media companies to be willing to work with Flipboard for a similar "if you can't beat 'em, join 'em" reason: Its app has their apps beat in terms of customizability and usability, so they're better off trying to make money off of it than their own internal options, Synthroid No Rx. ReadWriteWeb's Dan Rowinski wrote about the possibility that Flipboard could be a better alternative partner for publishers than Apple, and Marshall Kirkpatrick wondered why publishers are up in arms about Flipboard in the first place.

—

Traditional media's personalized news move: One of the reasons that media companies might be less than willing to work with Flipboard is that some of them are building their own personalized news aggregation apps, two of which launched this week: The Washington Post Co.'s Trove and Betaworks' News.me, developed with the New York Times, buy Synthroid without prescription. INFOdocket's Gary Price has the best breakdown of what Trove does: It uses your Facebook account and in-app reading habits to give you personalized "channels" of news, determined by an algorithm and editors' picks — a bit of the "Pandora for news" idea, as the Post's Don Graham called it. (It's free, Synthroid steet value, so it's got that going for it, which is nice.)

All Things Digital's Peter Kafka suspected that Trove will be most useful on mobile media, as its web interface won't be much different from many people's current personalized home pages, and David Zax of Fast Company emphasized the social aspect of the service.

News.me is different from Trove in a number of ways Synthroid No Rx, : It costs 99 cents a week, and it's based not on your reading history, but on what other people on Twitter are reading. (Not just what they're tweeting, but what they're reading — Betaworks' John Borthwick called it reading "over other people's shoulders.") It also pays publishers based on the number of people who read their content through the app, Synthroid duration. That's part of the reason it's gotten the blessing of some media organizations that aren't typically aggregator friendly, like the Associated Press.

Since News.me is based so heavily on Twitter, it raises the obvious question of whether you'd be better off just getting your news for free from Twitter itself. Synthroid mg, That's what Business Insider's Ellis Hamburger wondered, and Gizmodo's Adrian Covert answered a definitive 'no,' though Martin Bryant of The Next Web said it could be helpful in stripping out the chatter of Twitter and adding an algorithmic aspect. GigaOM's Mathew Ingram looked at both services and concluded that they signal a willingness by some traditional media outlets to adjust their longtime broadcasting role to the modern model of the "Daily Me."

—

A good sign for the Times' pay plan: The overall news from the New York Times Co.'s quarterly earnings report this week wasn't good — net income is down 57% from a year ago — but there was one silver lining for online paid-content advocates: More than 100,000 people have begun paying for the Times' website since it began charging for access last month, Synthroid No Rx. (That number doesn't include those who got free subscriptions via Lincoln, but it does include those who are paying though cheaper introductory trials.)

As Advertising Age's Nat Ives pointed out, there's a lot that number doesn't tell us about traffic and revenue (particularly, where can i cheapest Synthroid online, as paidContent's Staci Kramer noted, how many people are paying full price for their subscriptions), but several folks, including Glynnis MacNicol of Business Insider, Low dose Synthroid, were surprised at how well the Times' pay plan is doing. (Its goal for the first year was 300,000 subscribers.) She said the figure compares favorably with the Financial Times, which got its 200,000th subscriber this year, nine years into its paywall, Synthroid canada, mexico, india.

Those numbers are particularly critical for the Times given the difficulty its company has had over the past several years — as Katie Feola of Adweek wrote, many analysts believe the pay plan is crucial for the Times' financial viability. "But this means the paper's future rests on an untested model that many experts believe can't work in the oversaturated news market," she wrote. "And the Times has to pray the ad market won’t decline faster than analysts predict."

A few other paid-content tidbits: Nine of Slovakia's largest news organizations put up a paywall together this week, and the pope is apparently pro-paywall, Synthroid use, too. At the Guardian, Cory Doctorow mused about how companies can (and can't) get people to pay for the content online in an age of piracy.

—

Google's hammer falls on eHow: When Google applied its algorithm adjustment last month Synthroid No Rx, to crack down on content farms, Demand Media's eHow actually came out better off (though others didn't fare so well, like the New York Times Co.'s About.com, as we found out this week). Google made a second round of updates last week, and eHow got nailed this time, losing 66% of their Googlejuice, Synthroid from mexico, according to Sistrix.

Search Engine Land's Matt McGee speculated that Google might have actually been surprised when eHow benefited the first time, and may have made this tweak in part as an effort to "correct" that. Demand Media, Synthroid treatment, meanwhile, called Sistrix's eHow numbers"significantly overstated," though the company's stock hit a new low on Monday. Mathew Ingram said investors have reason to worry, as Demand's success seems to be at the mercy of Google's every algorithm tweak.

—

A Pulitzer first: The Pulitzer Prizes were announced this week, and while the awards were spread pretty broadly among several news organizations, there were a couple of themes to note, Synthroid No Rx. As Felix Salmon and others pointed out, buy generic Synthroid, an abnormally large share of the awards went to business journalism, a trend the Columbia Journalism Review's Dean Starkman opined on in a bit more detail.

The biggest prize from a future-of-news perspective may have gone to ProPublica, whose series on some of the machinations that worsened the financial crisis was the first Pulitzer winner to never appear in print. Purchase Synthroid online, The Lab's Justin Ellis noted that other winners are including significant multimedia components, perhaps signaling a shift in the emphasis of one of journalism's most elite institutions. If you were wondering where WikiLeaks was in all this, well, the New York Times didn't submit its WikiLeaks-based coverage.

—

Reading roundup Synthroid No Rx, : No huge stories this week, but a few little things that are worth noting:

— Your weekly AOL/Huffington Post update: Jonathan Tasini came out swinging again regarding his lawsuit on behalf of unpaid HuffPo bloggers, Business Insider's Glynnis MacNicol responded in kind, Eric Snider told the story of getting axed from AOL's now-defunct Cinematical blog, and HuffPo unveiled features allowing readers to follow topics and writers.

— Missouri j-school students are chafing against requirements that they buy an iPad (they previously had to buy iPod Touches, canada, mexico, india, and they called that plan a bust). Meanwhile, Ben LaMothe of 10,000 Words had three ideas of social media skills that j-schools should teach.

— A weird little fake-URL spoof turned into an interesting discussion about the possibility of libel through fake URLs, in thoughtful posts by both the Lab's Andrew Phelps and TechCrunch's Paul Carr.

— Two interesting data points on news innovation: A group led by Daniel Bachhuber put together some fascinating figures about and perspectives from Knight News Challenge grant recipients. And journalism researchers Seth Lewis and Tanja Aitamurto wrote at the Lab about news organizations using open API as a sort of external R&D department.

Similar posts: Order Armour. Glucophage Dosage. Lipitor Mg. Effects of Lipitor. Where can i order Retin A without prescription. Flagyl photos.
Trackbacks from: Synthroid No Rx. Synthroid No Rx. Synthroid No Rx. Synthroid pictures. Synthroid pics. Synthroid overnight.

[This review was originally posted at the Nieman Journalism Lab Flagyl Cost, on April 15, 2011.]

Are HuffPo bloggers being exploited?: Arianna Huffington spent last week axing many of AOL's paid writers, and this week she heard from a few of the unpaid ones in the form of a class-action lawsuit filed by Huffington Post bloggers, led by longtime HuffPo blogger Jonathan Tasini. The Washington Post explained Tasini's claims that HuffPo had breached its contract with bloggers by failing to come through the "implied promise" of compensation, and that it was "unjustly enriched" by the unpaid bloggers' contributions.  PaidContent, Buy Flagyl without a prescription, meanwhile, said this suit isn't much like Tasini's suit against The New York Times.

Reaction to the suit online was virtually universal: Most everyone agreed that this suit is a non-starter. Huffington herself did the best job of bringing together the various suit slams, arguing, like many of them, buy Flagyl from mexico, that the exposure that HuffPo provides is plenty of compensation for its bloggers: "People blog on HuffPost for free for the same reason they go on cable TV shows every night for free: either because they are passionate about their ideas or because they have something to promote and want exposure to large and multiple audiences."

Many of the critiques of the suit make similar points, so I'll just hit the highlights. Mike Masnick of TechDirt put the sharpest point on it: "You, Flagyl forum, of your own free will, agree to contribute work for free. Then, you file a lawsuit complaining that this is depressing the market for your work, Flagyl Cost. And you expect anyone to take you seriously?" Business Insider's Glynnis MacNicol and Slate's Jack Shafer also made the argument well, with MacNicol speaking from experience as a HuffPo blogger and Shafer noting that Tasini was happy with his arrangement until he saw some money could be had.

Others extended Tasini's logic to more absurd conclusions: Conservative legal blogger Eugene Volokh said if Tasini were right, order Flagyl online c.o.d, he'd be exploiting his commenters, and CUNY j-prof Jeff Jarvis extended the same analogy to Wikipedians and Little League coaches. PR professional Simon Owens saw a dangerous precedent for other sites with free contributors. Discount Flagyl, John Bethune of B2B Memes wrote, tongue-in-cheek, that perhaps Huffington owes all of us some money for making her site valuable by reading it over the years.

Still Huffington's way obviously isn't the only one: Forbes' Jeff Bercovici talked to the New York Times Flagyl Cost, about why they pay their (non-public figure) op-ed contributors. And a few other notes about Huffington's ongoing AOL revamp — Advertising Age's Michael Learmonth on AOL's new aggregation-heavy strategy, Patch is hiring as the new model is extended to its sites, order Flagyl from mexican pharmacy, and Bercovici's account of the grievances of the newly laid-off "freelancers."

—

Some unclear data on the Times' pay plan: It's only been a couple of weeks since the New York Times put up its metered pay system, but we got our first glimpse at its effect on the Times' traffic this week with some numbers from Heather Dougherty at Hitwise. Compared with the 12 days before the system went into place, Doses Flagyl work, the Times' unique visitors down between 5% and 15% per day and its page views down 11% to 30%. PaidContent's Joseph Tarkatoff has a few good bits of analysis of the figures.

Those numbers fell in that ambiguous no man's land between success and failure, allowing both supporters and skeptics of the plan to claim them as confirmation. Nate Silver of the Times' FiveThirtyEight called the data "very promising" if it holds, and Business Insider's Noah Davis noted that the Times' dropoff was smaller than Gawker's post-redesign decline, cheap Flagyl. On the other side, Mathew Ingram of GigaOM said that 15% is a high number of its readers for the Times to lose, suggesting that even the threat of a paywall has been enough to deter them from visiting, Flagyl Cost. Likewise, Mike Masnick of Techdirt called it "an awful lot of potential ad revenue lost."

Others were less willing to make pronouncements: VentureBeat's Anthony Ha called the change "only natural" but said it could be dangerous if it continues. Both he and Chris O'Shea of FishbowlNY said it's too early to determine anything meaningful yet, Buy Flagyl online no prescription, though. Media analyst Ken Doctor, meanwhile, took a closer look at the Times' subscription sponsorship deal with the carmaker Lincoln.

Elsewhere in the world of online news paywalls, Flagyl class, paidContent's Robert Andrews reported on the UK government's ongoing efforts to make walled-off material available for free through libraries, and Mashable's Meghan Peters explored the ways paywalls are affecting news orgs' social media strategies.

—

Identifying devoted fans through Facebook: Facebook launched Flagyl Cost, a new "Journalists on Facebook" page last week as part of an effort to draw attention to its possible uses for news organizations, and Josh Constine of Inside Facebook argued this week that while the journalism world seems to be particularly enamored with Twitter right now, Facebook's richer content options could pay off more in the long run, though they might require more effort than Twitter does.

The New Yorker tried out one of those Facebook-centric strategies in a novel way this week by making a Jonathan Franzen story available online only to people who "liked" Conde Nast on Facebook. Flagyl dose, The magazine's spokeswoman, Alexa Cassanos, told Poynter's Damon Kiesow the "like-wall" was not an effort to boost its Facebook fan count, but to find people who are fans of long-form journalism on a deeper level. Rather than a pile of casually interested fans, about Flagyl, Cassanos said, "We would much rather have a few thousand fans who really enjoy the content and stick with it."

On the Twitter side of things, former CEO Evan Williams wrote a thoughtful post trying to untangle the thicket of online identity by organizing it into a framework of categories he developed with Twitter CTO Greg Pass: Authentication, Flagyl pharmacy, representation, communication, personalization, and reputation. (I should note that while the framework was developed at Twitter, order Flagyl online overnight delivery no prescription, it was thought up with the whole web in mind.) Tech conference organizer Eric Norlin tweaked Williams' categories and suggested breaking it down by the specificity with which things are associated with us.

Web thinker Stowe Boyd, meanwhile, critiqued it as being too tools- or marketing-centric while ignoring the more philosophical aspects of online identity, like publicy and context, Flagyl Cost. Mathew Ingram of GigaOM concurred with him, saying that a transactional idea of identity misses the larger, Buy cheap Flagyl no rx, messier aspects of how we define ourselves online, offering the failure of Google Buzz as an example.

—

Reading roundup: Lots of little bits and pieces this week to go with our continued fixation on AOL and the New York Times. Here's a quick tour:

— I'm a bit surprised it didn't generate more buzz, but WikiLeaks' Julian Assange made his first public appearance since his December arrest last weekend, defending WikiLeaks' accountability at a British debate, and taking questions via Skype at a UC-Berkeley conference.

— A couple of interesting items regarding linking: Reuters' Anthony DeRosa wondered why traditional media orgs don't link out more, and USC's Robert Niles talked to Maryland j-prof Ronald Yaros about a study he led that found that explanatory links work best in news stories — provided they're placed inside explanatory text.

— According to Poynter's Damon Kiesow, we got a surprising entry in the iPad news app field this week: Bing.

— Finally, two thoughtful pieces — one from British journalist Kevin Anderson on the need to rethink what exactly newspapers do, and an interview by the Lab's C.W. Anderson with the Reuters Institute's David Levy and Danish j-prof Rasmus Kleis Nielsen on the need to take the future-of-news conversation beyond the U.S.

Similar posts: Glucophage No Rx. Cephalexin Price. Glucophage For Sale. Herbal Tramadol. Cephalexin interactions. Cephalexin overnight.
Trackbacks from: Flagyl Cost. Flagyl Cost. Flagyl Cost. Flagyl natural. Where can i order Flagyl without prescription. Cheap Flagyl no rx.

[This review was originally posted at the Nieman Journalism Lab Bactrim For Sale, on April 1, 2011.]

Putting the Times' pay plan in place: If you read last week's review, the first half of this week's should feel like déjà vu — lots of back-and-forth about the wisdom of The New York Times' new online pay plan, and some more hand-wringing about getting around that plan. If you want to skip that and get to the best stuff, I recommend Staci Kramer, David Cohn, and Megan Garber.

The Times launched its pay system Monday with a letter to its readers (snarkier version courtesy of Danny Sullivan), along with a 99-cent trial offer for the first four weeks and free access for people who subscribe to the Times on Kindle, Bactrim price. Times digital chief Martin Nisenholtz gave a launch-day talk to newspaper execs, highlighted by his assertion that the link economy is not a win-win for content producers and aggregators.

Meanwhile, the discussion about the paywall's worth rolled on. You can find a good cross-section of opinions in this On Point conversation with Ken Doctor, the Journal Register's John Paton, The Times' David Carr, and NYTClean creator David Hayes, Bactrim For Sale. The plan continues to draw support from some corners, Get Bactrim, including The Onion (in its typically ironic style, of course) and PC Magazine's Lance Ulanoff. Former Financial Times reporter Tom Foremski and Advertising Age columnist Simon Dumenco both made similar arguments about the value of the plan, where can i buy cheapest Bactrim online, with Foremski urging us to support the Times as a moral duty to quality journalism and Dumenco ripping the blogosphere's paywall-bashers for not doing original reporting like the Times.

And though the opposition was expressed much more strongly the past two weeks, there was a smattering of dissent about the plan this week, too — some from the Times' mobile users. One theme among the criticism was the cost of developing the plan: Philip Greenspun wondered how the heck the Times spent $40 million on planning and implementation, and former Guardian digital head Emily Bell wrote about the opportunity cost of that kind of investment. Rx free Bactrim, BNET's Erik Sherman proposed that the Times should have invested the money in innovation instead.

A few other interesting thoughts about the Times' pay plan before we get to the wall-jumping debate: Media consultant Judy Sims said the plan might actually make the Times more social Bactrim For Sale, by providing an incentive for subscribers to share articles on social networks to their non-subscribing friends. Spot.Us' David Cohn argued that the plan is much closer to a donation model than a paywall and argued for the Times to offer membership incentives. And Reuters' Felix Salmon talked about how the proposal is changing blogging at the Times.

PaidContent's Staci Kramer said the Times is fighting an uphill battle in the realm of public perception, but that struggle is the Times' own fault, created by its way-too-complicated pay system.

—

The ethics of paywall jumping: With the Times' "pay fence" going into effect, Bactrim pictures, all the talk about ways to get around that fence turned into a practical reality. Business Insider compiled seven of the methods that have been suggested: A browser extension, Twitter feeds, using different computers, NYTClean and a User Script's coding magic, Google (for five articles a day), and browser-switching or cookie-deleting, Bactrim For Sale. Mashable came up with an even simpler one: delete "?gwh=numbers" from the Times page's URL.

Despite such easy workarounds, the Times is still cracking down in other areas: As Search Engine Land's Danny Sullivan noted, it blocks links from all Google sites after the five-articles-per-day limit is reached. Bactrim price, coupon, The Times also quickly (and successfully) requested a shutdown of one of the more brazen free-riding schemes yet concocted — NYT for a Nickel, which charged to access Times articles without paywall restrictions. (It did, however, let up on unauthorized Twitter aggregators of Times content.)

So we all obviously can crawl through the Times' loopholes, but should we. A few folks made efforts to hack through the ethical thicket of the Times' intentional and unintentional loopholes: Times media critic James Poniewozik didn't come down anywhere solid Bactrim For Sale, , but said the Times' leaky strategy "makes the paywall something like a glorified tip jar, on a massive scale—something you choose to contribute to without compulsion because it is the right thing" — except unlike those enterprises, it's for-profit. In a more philosophical take, the Lab's Megan Garber said the ethical conundrum shows the difficulty of trying to graft the physical world's ethical assumptions onto the digital world.

—

A possible +1 for publishers: Google made a big step in the direction of socially driven search this week with the introduction of +1, purchase Bactrim online, a new feature that allows users to vote up certain search results in actions that are visible to their social network. Here are two good explainers of the feature from TechCrunch and Search Engine Land, both of whom note that +1's gold mine is in allowing Google to personalize ads more closely, and that it's starting on search results and eventually moving to sites across the web.

The feature was immediately compared to Facebook's "Like" and Twitter's retweets, Bactrim no rx, though it functions a bit differently from either. As GigaOM's Mathew Ingram noted, because it's Google, it's intrinsically tied to search, which is both an advantage and a disadvantage. As Ingram said, it's smart to add more of a social component to search, but Google's search-centricity makes the "social network" aspect of +1 awkward, just as Buzz and Wave were, Bactrim For Sale. To paraphrase the argument of Frederic Lardinois of NewsGrange: if your +1's go into your Google Profile and no one sees them, do they really make a sound, generic Bactrim.

All this seems to be good news for media sites. Lost Remote's Cory Bergman said that if they essentially become "improve the SEO of this site" buttons, media companies will be pretty motivated to add them to their sites. Likewise, Poynter's Damon Kiesow reasoned that +1 could be a great way for media sites to more deeply involve visitors who arrive via Google, Bactrim duration, who have typically been less engaged than visitors from Facebook and Twitter.

—

Shrinking innovation to spur it: This month's Carnival of Journalism Bactrim For Sale, focuses on how to drive innovation, specifically through the Knight News Challenge and Reynolds Journalism Institute. Most of the posts rolled in yesterday, and they contain a litany of quick, smart ideas of new directions for news innovation and how to encourage it.

A quick sampling: City University London and Birmingham City University j-prof Paul Bradshaw proposed a much broader, smaller-scale News Challenge fund, with a second fund aimed at making those initiatives scale, where can i buy Bactrim online. J-Lab Jan Schaffer said we need to quit looking at innovation so much solely in terms of tools and more in terms of processes and relationships. British journalist Mary Hamilton and Drury j-prof Jonathan Groves both focused on innovation in training, with Groves proposing "innovation change agents" funded by groups like Knight and the RJI to train and transform newsrooms.

Also, University of British Columbia j-prof Alfred Hermida opined on the role of theory in innovation, Lisa Williams of Placeblogger advocated a small-scale approach to innovation, and the University of Colorado's Steve Outing had some suggestions for the RJI fellowship program, Bactrim For Sale.

—

The mechanics of Twitter's information flow: Four researchers from Yahoo and Cornell released a study this week analyzing, as they called it, Buy Bactrim no prescription, "who says what to whom on Twitter." One of their major findings was that half the information consumed on Twitter comes from a group of 20,000 "elite" users — media companies, celebrities, organizations and bloggers. As Mathew Ingram of GigaOM observed, that indicates that the power law that governs the blogosphere is also in effect on Twitter, and big brands are still important even on a user-directed platform, Bactrim no prescription.

The Lab's Megan Garber noted a few other interesting implications of the study, delving into Twitter's two-step flow from media to a layer of influential sources to the masses, as well as the social media longevity of multimedia and list-oriented articles. A couple of other research-oriented items about Twitter: A Lab post on Dan Zarrella's data regarding timing and Twitter posts, and Maryland prof Zeynep Tufekci wrote a more theoretical post on NPR's Andy Carvin and the process of news production on Twitter.

—

Reading roundup: Plenty of other bits and pieces around the future-of-news world this week:

— New York Times editor Bill Keller wrote a second column Bactrim For Sale, , and like his anti-aggregation piece a couple of weeks ago, this piece — about the value of the Times' impartiality and fact-based reporting — didn't go over well. Buy Bactrim without prescription, Reuters' Felix Salmon called him intellectually dishonest, Scott Rosenberg called him defensive, and the Huffington Post's Peter Goodman (a former Times reporter) said Keller misrepresented him.

— A few notes on The Daily: Forbes' Jeff Bercovici said it was downloaded 500,000 times during its trial period and has 70,000 regular users, and a study was conducted finding that it's more popular with less tech-savvy, purchase Bactrim for sale, less content-concerned users.

— Journal Register Co. CEO John Paton talked about transforming newspapers at the Newspaper Association of America convention; he summarized what he had to say in 10 tweets, and Alan Mutter wrote a post about the panel. The moderator, Ken Doctor, wrote a Lab post looking at how long newspapers have left.

— I'll send you off with Jonathan Stray's thoughtful post on rethinking journalism as a system for informing people, rather than just a series of stories. It's a lot to chew on, but a key piece to add to the future-of-news puzzle.

Similar posts: Buy Tramadol No Prescription. Order Flagyl. Tramadol Over The Counter. Purchase Armour. Cheap Retin A no rx. Purchase Glucophage for sale.
Trackbacks from: Bactrim For Sale. Bactrim For Sale. Bactrim For Sale. Bactrim dosage. Ordering Bactrim online. Buy cheap Bactrim no rx.

[This review was originally posted at the Nieman Journalism Lab Synthroid Cost, on March 25, 2011.]

Debating the Times’ pricing structure: There was really only one big news story in the media world this week: The New York Times’ paid-content plan, which is live in Canada now and coming to everyone else on Monday. I divided the issue into two sections — the first on general commentary on the plan, and the second specifically about efforts to get around the paywall.

We learned a bit more about the Times’ thinking behind the plan, with a story in the Times about the road from its last paid-content system, TimesSelect, to this one, Synthroid treatment, and an All Things Digital interview with Times digital chief Martin Nisenholtz, in which he said, among other things, that the Times didn’t consider print prices when setting their online price levels. Order Synthroid no prescription, Former Times designer Khoi Vinh also looked at the last couple of years, lamenting the lost opportunity for innovation and the legacy of TimesSelect.

There were a couple of pieces written supporting the Times’ proposal: Former CBS digital head Larry Kramer said he’d be more likely to pay for the Times than for the tablet publication The Daily, even though it’s far more expensive. The reason. The Times’ content has consistently proven to be valuable over the years. (Tech blogger John Gruber also said the Times’ content is much more valuable than The Daily’s, but wondered if it was really worth more than five times more money.) Nate Silver of Times blog FiveThirtyEight used some data to argue for the Times’ value.

The Times’ own David Carr offered the most full-throated defense of the pay plan, arguing that most of the objection to it is based on the “theology” of open networks and the free flow of information, rather than the practical concerns involved with running a news organization, Synthroid Cost. Reuters’ Felix Salmon countered that the Times has its own theology — that news orgs should charge for content because they can, Synthroid mg, and that it will ensure their success. Later, though, Salmon ran a few numbers and posited that the paywall could be a success if everything breaks right.

There were more objections voiced, Synthroid dosage, too: Both Mathew Ingram of GigaOM and former newspaper journalist Janet Coats both called it backward-looking, with Ingram saying it “seems fundamentally reactionary, and displays a disappointing lack of imagination.” TechDirt’s Mike Masnick ripped the idea that people might have felt guilty about getting the Times for free online.

One of the biggest complaints revolved around the Times’ pricing system itself, which French media analyst Frederic Filloux described as “expensive, utterly complicated, disconnected from the reality and designed to be bypassed.” Others, Synthroid samples, including Ken Doctor, venture capitalist Jean-Louis Gassee, and John Gruber, made similar points about the proposal’s complexity, Synthroid recreational, and Michael DeGusta said the prices are just too high. Poynter’s Damon Kiesow disagreed about the plan structure, arguing that it’s well-designed as an attack on Apple’s mobile paid-content dominance.

—

Are paywall loopholes a bug or feature?: Of course, any barrier online is also a giant, flashing invitation to get around said barrier, and someplace as influential as the Times was not going to be an exception, online Synthroid without a prescription. Several ways to bypass the Times’ pay system popped up in the last week: There was @FreeNYT, the Twitter account that will aggregate Times content shared on Twitter, and NYTClean, a browser bookmarklet that strips the Times’ paywall coding, allowing you to read the Times just like normal. The Lab’s Josh Benton noted how easy the hack was to come up with (four lines of code!) and speculated that  Synthroid Cost, the Times might actually want nerds to game their system, “because they (a) are unlikely to pay, (b) generate ad revenue, and (c) are more likely to share your content than most.”

So how has the Times responded to all this. A bit schizophrenically. Publisher Arthur Sulzberger Jr, buy no prescription Synthroid online. said the people who would find ways around the system would be “mostly high-school kids and people who are out of work.” And the Times asked Twitter to shut down the aggregating Twitter accounts (for a trademark violation) and extended its limit on daily search-engine referrals beyond Google. But the Times is also widening some pathways of its own, making it so you can’t hit the wall directly from a blog link, and offering 200, Synthroid australia, uk, us, usa, 000 regular readers free online access for the rest of the year through an advertiser.

Search Engine Land’s Danny Sullivan mocked the Times’ behavior toward wall-jumpers as an effort to have its paid-content cake and eat it too: “This wall is designed, as best I can tell, only to be a barrier to your most loyal — and most stupid — readers.” Slate’s Jack Shafer made a similar argument to Benton’s, pointing out that online free-riders aren’t keeping paying customers from reading the Times (like, say, someone who steals a paper edition, Synthroid trusted pharmacy reviews, as Sulzberger analogized) and are actually help the paper continue its influence and reach.

—

Adding community to local data: EveryBlock, a three-year-old site owned by MSNBC.com that specializes in hyperlocal news data, unveiled its first major redesign this week, which includes a shift in focus toward community and location-based conversation, Synthroid coupon, rather than just data. All place pages now allow users to post messages to those nearby, using what founder Adrian Holovaty called the “geo graph,” rather than the “social graph.” Mashable added a few valuable details (notably, the site will bring in revenue from location-based Groupon displays and Google ads).

Holovaty answered a lot of questions about the redesign in a Poynter chat, saying that the site’s mission has changed from making people informed about their area as an end in itself to facilitating communication between neighbors in order to improve their communities, Synthroid Cost. GigaOM’s Mathew Ingram applauded the shift in thinking, arguing that the main value in local news sites is in the people they connect, not in the data they collect. At 10,000 Words, comprar en línea Synthroid, comprar Synthroid baratos, Jessica Roy noted that the change was a signal that hyperlocal sites should focus not just on the online realm, but on fostering offline connections as well.

—

NPR on the defensive: Two weeks on, the hidden-camera attack on NPR continues to keep it in the middle of the news conversation. Following last week’s vote by the House to cut off NPR’s limited federal funding, Synthroid canada, mexico, india, several media folks made cases to keep NPR’s federal funding alive, including the Washington Post’s Len Downie and Robert Kaiser and Poynter’s Roy Peter Clark. NPR host Steve Inskeep argued that NPR’s most important work has nothing to do with any liberal/conservative bias. “Think again of my colleagues in Libya, going forward to bear witness amid exploding shells. Is that liberal or conservative?” he asked.

Synthroid Cost, Elsewhere, James O’Keefe, the producer of the gotcha video, and Bob Garfield of NPR’s On The Media had it out on the air, and DailyFinance gave a picture of NPR’s financial situation. Howard Kurtz of Newsweek and The Daily Beast wrote that some NPR journalists think that NPR management’s passive, reactionary defense of their organization is damaging it almost as much as the attacks themselves.

—

Reading roundup: Not too busy of a week in the media world outside of Timesmania, Synthroid without a prescription. A few things to take note of:

— A quick news item: Journalism Online, Steve Brill’s initiative to help media companies charge for their content online, is being snatched up by the Fortune 500 printer RR Donnelley, reportedly for at least $35 million. PaidContent broke the story, and Ken Doctor wrote about the unexpected difficulties the startup encountered.

— At the New York Review of Books, Steve Coll wrote a thoughtful piece on the competing claims regarding technology’s role in social change.

— For the stat nerds: The Lab’s Josh Benton looked at the latest of the continual stream of depressing graphs flowing from the newspaper industry, and Peter Kafka of All Things Digital analyzed the source of traffic for some major sites across the web, comparing the influence of Facebook and Google.

— For the academic nerds: Here at the Lab, USC Ph.D. candidate Nikki Usher talked to media sociology rock star Herbert Gans about targeted and multiperspectival news, and Michigan Ph.D. candidates William Youmans and Katie Brown shared a fascinating study about Al Jazeera and bias perception.

Similar posts: Retin A Price. Order Lipitor. Synthroid Over The Counter. Synthroid no rx. Buy Retin A no prescription. Diflucan from canada.
Trackbacks from: Synthroid Cost. Synthroid Cost. Synthroid Cost. Buy Synthroid without a prescription. Synthroid no prescription. Synthroid long term.